BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld
BioWorld
Sep. 18, 2002
View Archived Issues
Genentech, XOMA Come Through With Strong Phase III Raptiva Data
When trying to get a drug approved, biotechnology companies must provide the FDA with data - data showing that a drug is efficacious, that it works in the appropriate patient and that it is safe, among other things. (BioWorld Today)
Read More
Trimeris, Roche Submit NDA Seeking Approval Of Fuzeon
Read More
Little-Known MSR1 Gene Links Prostate Cancer, Heart Disease, Macrophages, Atherosclerosis
Read More
IDEC Collaborates With Caprion On Proteomics-Based Discovery
Read More
Other News To Note
Read More
Onyx Regains Remainder Of Rights To ONYX-015 Program
Read More
